Kohno Masayuki | Department Of Pharmacoepidemiology Graduate School Of Medicine And Public Health Kyoto University:department Of R & D Promotion Upstream Infinity Inc.
スポンサーリンク
概要
- KOHNO Masayukiの詳細を見る
- 同名の論文著者
- Department Of Pharmacoepidemiology Graduate School Of Medicine And Public Health Kyoto University:department Of R & D Promotion Upstream Infinity Inc.の論文著者
関連著者
-
Kawakami Koji
Department Of Pharmacoepidemiology Graduate School Of Medicine And Public Health Kyoto University
-
Kohno Masayuki
Department Of Pharmacoepidemiology Graduate School Of Medicine And Public Health Kyoto University
-
Horibe Tomohisa
Department Of Pharmacoepidemiology Graduate School Of Medicine And Public Health Kyoto University
-
Kohno Masayuki
Department Of Pharmacoepidemiology Graduate School Of Medicine And Public Health Kyoto University:department Of R & D Promotion Upstream Infinity Inc.
-
Kawakami Koji
Department Of Otorhinolaryngology Yokohama City University School Of Medicine
-
HORIBE Tomohisa
Department of Bioscience & Technology, Faculty of Science & Engineering, Ritsumeikan University
-
Ohara Koji
Department Of Pharmacoepidemiology Graduate School Of Medicine And Public Health Kyoto University
-
KOHNO Masayuki
Department of Pharmacology, Graduate School of Medicine and Public Health, Kyoto University
-
Ohara Koji
Department Of Microbiology Tokyo College Of Pharmacy
-
YANG Liying
Department of Pharmacology, Graduate School of Medicine and Public Health, Kyoto University
-
HORIBE Tomohisa
Depaartment of Pharamacoepidemiology, Graduate School of Medicine and Public Health, Kyoto Universit
-
KOHNO Masayuki
Depaartment of Pharamacoepidemiology, Graduate School of Medicine and Public Health, Kyoto Universit
-
KAWAKAMI Koji
Depaartment of Pharamacoepidemiology, Graduate School of Medicine and Public Health, Kyoto Universit
-
HARAMOTO Mari
Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University
-
Yang Liying
Department Of Pharmacoepidemiology Graduate School Of Medicine And Public Health Kyoto University
-
Haramoto Mari
Department Of Pharmacoepidemiology Graduate School Of Medicine And Public Health Kyoto University
-
Kawamoto Megumi
Depaartment Of Pharamacoepidemiology Graduate School Of Medicine And Public Health Kyoto University
-
Kawamoto Megumi
Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University
-
Kawamoto Megumi
Department Of Pharmacoepidemiology Graduate School Of Medicine And Public Health Kyoto University
-
UEYAMA Hanae
Department of Pharmacology, Graduate School of Medicine and Public Health, Kyoto University
-
NAKAJIMA Oumi
Department of Pharmacology, Graduate School of Medicine and Public Health, Kyoto University
-
HARAMOTO Mari
Depaartment of Pharamacoepidemiology, Graduate School of Medicine and Public Health, Kyoto Universit
-
OHARA Koji
Depaartment of Pharamacoepidemiology, Graduate School of Medicine and Public Health, Kyoto Universit
-
KODAMA Kumi
Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University
-
TORISAWA Aya
Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University
-
KAWAMOTO Megumi
Depaartment of Pharamacoepidemiology, Graduate School of Medicine and Public Health, Kyoto Universit
-
Kodama Kumi
Department Of Pharmacoepidemiology Graduate School Of Medicine And Public Health Kyoto University
-
Ueyama Hanae
Department Of Pharmacology Graduate School Of Medicine And Public Health Kyoto University
-
Torisawa Aya
Department Of Pharmacoepidemiology Graduate School Of Medicine And Public Health Kyoto University
-
Nakajima Oumi
Department Of Pharmacology Graduate School Of Medicine And Public Health Kyoto University
-
Nakajima Oumi
Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University
著作論文
- Characterization of a novel Neuropilin-1 targeted hybrid peptide disintegrating cancer cell membrane
- Mechanism of Cancer Cell Death by Novel Hybrid TPR Peptide Targeting Hsp90
- Antitumor effect of the EGFR-lytic hybrid peptide in animal model of human cancers with K-ras mutation
- Effective in vitro and in vivo Antitumor Activity of Hybrid IL4-lytic Peptide
- A Novel Hybrid Peptide That Binds Transferrin Receptor and Induces Rapid Permeation of Cancer Cell Membrane
- Cytotoxic activity to acute myeloid leukemia cells by Antp-TPR hybrid peptide targeting Hsp90(MEDICAL BIOTECHNOLOGY)